{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:18:49Z","timestamp":1787897929251,"version":"build-2784847793"},"reference-count":66,"publisher":"Informa UK Limited","issue":"27","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,11,14]]},"DOI":"10.1080\/14796694.2025.2577337","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:51:52Z","timestamp":1761907912000},"page":"3545-3560","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Embedding genetic testing in the metastatic prostate cancer pathway: understanding patient and physician perspectives"],"prefix":"10.1080","volume":"21","author":[{"given":"Ruhee","family":"Jain","sequence":"first","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ribbands","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Butcher","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Barlow","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Skilling","sequence":"additional","affiliation":[{"name":"Adelphi Real World","place":["Bollington, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stevens","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["Raritan, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Pascoe","sequence":"additional","affiliation":[{"name":"Johnson & Johnson","place":["High Wycombe, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_8_4_1","unstructured":"National Cancer Institute: surveillance Epidemiology and End Results Program. Cancer stat facts: Prostate cancer. 2024. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.010"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.06.011"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001375"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001376"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.04.012"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312628"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.06.053"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.08.037"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.43.1882"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00029"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016\u20130135"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603144"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0153"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16462"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.11.033"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-018-0349-x"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00358"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.01.011"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2017.06.001"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.022"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102728"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S468680"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00887-z"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2025.501686"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.0812"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405095"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature03445"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0120"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802457040"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2023.2279679"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010352"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.05.021"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.7.758"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30684-9"},{"key":"e_1_3_8_39_1","article-title":"FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer","volume":"15","author":"US Food and Drug Administration","year":"2020","unstructured":"US Food and Drug Administration. FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer. May. 2020;15. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-rucaparib-brca-mutated-metastatic-castration-resistant-prostate","journal-title":"May"},{"key":"e_1_3_8_40_1","article-title":"FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer","volume":"19","author":"US Food and Drug Administration","year":"2020","unstructured":"US Food and Drug Administration. FDA approves olaparib for HRR gene-mutated metastatic castration-resistant prostate cancer. May. 2020;19. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-olaparib-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer","journal-title":"May"},{"key":"e_1_3_8_41_1","unstructured":"Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. [2021 Jun 24]. Available from: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2021\/lynparza-approved-in-china-for-prostate-cancer.html#!"},{"key":"e_1_3_8_42_1","unstructured":"Lynparza approved in the EU for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. 2020 Nov 5. Available from: https:\/\/www.astrazeneca.com\/media-centre\/press-releases\/2020\/lynparza-approved-in-the-eu-for-prostate-cancer.html"},{"key":"e_1_3_8_43_1","unstructured":"Lynparza\u00ae (olaparib) receives three new approvals in Japan. 2020 Dec 28. Available from: https:\/\/www.merck.com\/news\/lynparza-olaparib-receives-three-new-approvals-in-japan\/"},{"key":"e_1_3_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"e_1_3_8_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003452"},{"key":"e_1_3_8_46_1","unstructured":"Cancer Institute NSW. Prostate cancer \u2013 panel testing. ID: 3648 v.4. 2020. Available from: https:\/\/www.eviq.org.au\/cancer-genetics\/adult\/genetic-testing-using-cancer-gene-panels\/3648-prostate-cancer-panel-testing#genes-that-might-be-included-in-a-prostate-cancer"},{"key":"e_1_3_8_47_1","unstructured":"Cancer Institute NSW. Germline testing in individuals for whom BRCA1 and BRCA2 tumour testing may inform systemic therapy options ID: 4251 v.1. 2023. Available from: https:\/\/www.eviq.org.au\/cancer-genetics\/resources\/4251-germline-testing-in-individuals-for-whom-brca#prostate-cancer-metastatic-castrate-resistant"},{"key":"e_1_3_8_48_1","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.8588"},{"key":"e_1_3_8_49_1","unstructured":"National Comprehensive Cancer Network (NCCN). Prostate cancer. Version 2. 2025 Apr 16. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"e_1_3_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.04.005"},{"key":"e_1_3_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2024.07.113"},{"key":"e_1_3_8_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001570"},{"key":"e_1_3_8_53_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-1113"},{"key":"e_1_3_8_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad046"},{"key":"e_1_3_8_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.08.004"},{"key":"e_1_3_8_56_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00901-4"},{"key":"e_1_3_8_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2014.001701"},{"key":"e_1_3_8_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02768"},{"key":"e_1_3_8_59_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.35"},{"key":"e_1_3_8_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.23186"},{"key":"e_1_3_8_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00764-1"},{"key":"e_1_3_8_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_8_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14993"},{"key":"e_1_3_8_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24352"},{"key":"e_1_3_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.02.023"},{"key":"e_1_3_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.021"},{"key":"e_1_3_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2022.100588"},{"key":"e_1_3_8_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2510890"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2577337","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2025.2577337","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2577337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:53:46Z","timestamp":1787896426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2577337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":66,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2025,11,14]]}},"alternative-id":["10.1080\/14796694.2025.2577337"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2577337","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}